Managed Account Advisors’s Intersect ENT, Inc XENT Stock Holding History

Managed Account Advisors’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$26K	Buy	895 +6	+0.7%	+$157	﹤0.01%	2758
2015 Q1	$23K	Buy	+889	New	+$20.3K	﹤0.01%	2721

Other funds holding XENT

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

NVPX

Norwest Venture Partners XI Palo Alto, California $32.1M AUM 15.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Managed Account Advisors's XENT Position: Q2 2015 in Review

Managed Account Advisors increased its Intersect ENT, Inc (XENT) stake by 0.67% in Q2 2015, buying an estimated $157 and bringing the position to 895 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #2758.

Managed Account Advisors first reported a position in XENT in Q1 2015 and has held it in 2 quarters since. 128 funds tracked by Wall St. Rank hold XENT as of Q2 2015.

Managed Account Advisors held 895 shares of Intersect ENT, Inc worth $26K as of Q2 2015.
Managed Account Advisors bought 6 Intersect ENT, Inc shares in Q2 2015, an estimated $157.
Intersect ENT, Inc made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2758 holding.
Managed Account Advisors first reported a position in Intersect ENT, Inc in Q1 2015 and has held it in 2 quarters since.
128 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.